USPTO Examiner COLELLO ERIN L - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18409140STENT AND METHOD FOR USE THEREOFJanuary 2024February 2026Allow2540YesNo
18353233PFO DeviceJuly 2023September 2025Abandon2620NoNo
18208905STEERABLE MEDICAL DEVICEJune 2023May 2025Abandon2320NoNo
18078551COMPRESSION FORCE INDICATOR FOR ACHIEVING HEMOSTASISDecember 2022February 2026Abandon3811NoNo
17952809COMPRESSION DEVICE AND METHOD FOR ADHERING COMPRESSION DEVICESeptember 2022November 2025Abandon3811NoNo
17741904Ring of LifeMay 2022April 2025Abandon3610NoNo
17736118Medical Device And Method For Facilitating Selection Of An Annuloplasty ImplantMay 2022March 2024Abandon2220NoNo
17571247CARDIAC IMPLANTABLE ELECTRONIC DEVICE POCKET COMPRESSION APPARATUS AND METHOD OF MITIGATING LOCALIZED BLEEDING USING SAMEJanuary 2022September 2024Abandon3330YesNo
17431544MEDICAL DEVICE FOR BLOOD VESSEL COMPRESSIONAugust 2021September 2025Abandon4911NoNo
17396805Delivery Systems And Methods Of Implantation For Prosthetic Heart ValvesAugust 2021June 2025Abandon4621NoNo
17290195Sheath for Use in Performing Surgical Vascular Anastomotic Procedures, and Applications ThereofApril 2021August 2025Abandon5211NoNo
17289921METHOD AND DEVICE FOR VESICOURETHRAL ANASTOMOSISApril 2021February 2025Abandon4611NoNo
17192802VASCULAR ACCESS DEVICE AND RELATED SYSTEMS AND METHODSMarch 2021February 2026Allow6030YesNo
17175855Device for Mitigating the Ascension of Testicles During Castration of LivestockFebruary 2021April 2023Abandon2610NoNo
17152611STEERABLE ENDOLUMINAL PUNCH WITH CUTTING STYLETJanuary 2021September 2024Abandon4430NoNo
17145677CANNULA ASSEMBLY INCLUDING A SUCTION CUP SEALJanuary 2021May 2025Allow5240YesNo
17142091NEEDLE ASSEMBLYJanuary 2021May 2025Abandon5240NoNo
17140652KNOTLESS SUTURE ANCHORJanuary 2021March 2025Abandon5121NoNo
17254181PUNCTURE GUIDER AND PUNCTURE GUIDING SYSTEMDecember 2020April 2024Allow4010YesNo
17051809INTRAOCULAR SURGERY INSTRUMENT HOLDEROctober 2020July 2025Abandon5730YesNo
16873923Support strap with integrated windlss toumiquetAugust 2020May 2023Abandon3210NoNo
16993114LOW PROFILE ELECTRODES FOR A SHOCK WAVE CATHETERAugust 2020July 2025Allow5931YesNo
16992951WINDLASS PENAugust 2020October 2023Abandon3811NoNo
16988273VARYING DIAMETER VASCULAR IMPLANT AND BALLOONAugust 2020January 2024Abandon4230NoNo
16940133CARDIAC IMPLANTABLE ELECTRONIC DEVICE POCKET COMPRESSION APPARATUS AND METHOD OF MITIGATING LOCALIZED BLEEDING USING SAMEJuly 2020February 2025Abandon5550YesNo
16923885Catheter System and Method For Occluding A Body VesselJuly 2020November 2023Abandon4120YesNo
16922341Medical Device for the Insertion of a TubeJuly 2020August 2023Abandon3720YesNo
16888686METHOD AND TOOLS FOR CLEARING THE EPIDURAL SPACE IN PREPARATION FOR MEDICAL LEAD IMPLANTATIONMay 2020September 2024Abandon5140YesNo
16860199MANIPULATOR AND SURGERY SUPPORTING ROBOT SYSTEMApril 2020September 2023Allow4020YesNo
16827297INTERVENTIONAL RADIOLOGY SUTURE DEVICEMarch 2020February 2023Abandon3510NoNo
16746604POSITION-ADJUSTABLE DEVICE FOR TREATMENT OF TRICUSPID REGURGITATIONJanuary 2020March 2023Abandon3810NoNo
16711628STEERABLE MEDICAL DEVICEDecember 2019March 2023Allow4020NoNo
16667261MEDICAL IMPLANT DEPLOYMENT TOOLOctober 2019September 2022Abandon3510NoNo
16455303TOURNIQUETJune 2019October 2024Abandon6020NoNo
15983186DELIVERY AND DEPLOYMENT SYSTEMS FOR BIFURCATED STENT GRAFTSMay 2018February 2023Allow5720YesYes
15727980Laparoscopic Instrument with Attachable End EffectorOctober 2017November 2020Abandon3710NoNo
15721152VARYING DIAMETER VASCULAR IMPLANT AND BALLOONSeptember 2017December 2020Abandon3820NoNo
15663988ADJUSTABLE SURGICAL DEVICE WITH ULTRASOUND GUIDANCE AND RELATED TECHNIQUESJuly 2017March 2019Abandon1910NoNo
15610096CATHETER AND METHOD OF INSERTIONMay 2017August 2021Abandon5030NoNo
15432853COORDINATED DELIVERY OF COPD TREATMENTFebruary 2017June 2021Abandon5230NoNo
15320683Tissue Approximator DeviceDecember 2016March 2019Abandon2710NoNo
15382898Windlass Tourniquet With Embedded Writing ImplementDecember 2016February 2019Abandon2610NoNo
15379608SURGICAL GUIDANCE DEVICES, METHODS, AND SYSTEMSDecember 2016October 2020Allow4621YesNo
15294709Embolus Removal Device with Blood Flow Restriction and Related MethodsOctober 2016February 2019Abandon2810NoNo
15294708Embolus Removal Device with Blood Flow Restriction and Related MethodsOctober 2016February 2019Abandon2810NoNo
15285432MULTIPLE BARREL CLOT REMOVAL DEVICESOctober 2016November 2020Abandon5020NoNo
15279742BIODEGRADABLE VASCULAR FILTERSeptember 2016January 2021Abandon5221NoNo
15300276PROTECTION DEVICE FOR PREVENTING TUMOR DISSEMINATION AND TUMOR METASTASIS IN LAPAROSCOPIC SURGERYSeptember 2016November 2020Abandon5020NoNo
15300184SURGICAL APPARATUS, METHOD FOR USING THE SURGICAL APPARATUS AND SUTURE METHODSeptember 2016April 2019Abandon3001NoNo
15120522STEERABLE MEDICAL DEVICEAugust 2016April 2020Abandon4420NoNo
15109622ENDOSCOPIC CLIPJuly 2016December 2019Abandon4220NoNo
15100004SYSTEM FOR CONNECTING A MEDICAL IMPLANT TO AN INSERTION AIDMay 2016July 2019Allow3810NoNo
15165768OFF-CENTER TISSUE ANCHORS WITH TENSION MEMBERSMay 2016March 2022Allow6020YesNo
15087719AMNIO OPENING OCCLUSION DEVICEMarch 2016April 2019Abandon3620NoNo
15073118CATHETER SYSTEM AND TREATMENT METHODMarch 2016September 2022Allow6040YesNo
15067014PERIOSTEUM ELEVATION TIP AND METHOD OF USEMarch 2016November 2018Abandon3211NoNo
14913358METHOD AND DEVICE FOR RESTRICTING BLOOD FLOWFebruary 2016December 2020Allow5830YesNo
14909069HANDLE ASSEMBLY FOR IMPLANT DELIVERY APPARATUS COMPRISING A FORCE LIMITER, A DISPLACEMENT LIMITER AND/OR A BRAKE FRAME ASSEMBLYJanuary 2016April 2020Allow5020YesNo
14909063HANDLE ASSEMBLY FOR IMPLANT DELIVERY APPARATUS COMPRISING A FORCE LIMITER, A DISPLACEMENT LIMITER AND/OR A BRAKE FRAME ASSEMBLYJanuary 2016April 2020Allow5020YesNo
14939271EXPANDING HERNIA FIXATION TACKNovember 2015April 2020Abandon5321NoNo
14847492Knotless Suture AnchorSeptember 2015August 2020Allow6020NoNo
14762382A Medical Device And Method For Facilitating Selection Of An Annuloplasty ImplantJuly 2015March 2022Abandon6060NoYes
14790584ANASTOMOSIS DEVICES AND METHODS OF USING SAMEJuly 2015April 2019Abandon4521NoNo
14193747CATHETER SYSTEM WITH SPACER MEMBERFebruary 2014January 2020Abandon6050YesYes
14163840Delivery Systems And Methods Of Implantation For Prosthetic Heart ValvesJanuary 2014March 2021Allow6070NoYes
14036154DEPTH-ADJUST MECHANISM FOR LANCING DEVICESeptember 2013January 2019Allow6041NoNo
14034177RE-SHAPING INTRAGASTRIC IMPLANTSSeptember 2013April 2019Abandon6050NoNo
13612119MEDICAL IMPLANT DEPLOYMENT TOOLSeptember 2012November 2019Abandon6071YesYes
13489250Balloon Catheter With Non-Deployable StentJune 2012October 2022Allow6070YesYes
13322256DELIVERY SYSTEM FOR BRANCHED STENT GRAFTJanuary 2012April 2019Abandon6080NoNo
13025711METHOD FOR THE PRODUCTION OF A PACIFIER TEATFebruary 2011August 2020Allow6080YesNo
13014632STENT AND STENT DELIVERY SYSTEM WITH IMPROVED DELIVERABILITYJanuary 2011February 2022Allow6081YesNo
12942232Devices, Systems, and Methods for Prosthesis Delivery and Implantation, Including a Prosthesis AssemblyNovember 2010April 2019Abandon6080YesNo
12905456STEERABLE PERCUTANEOUS PADDLE STIMULATION LEADOctober 2010March 2021Allow6080NoYes
12904885SYSTEM FOR IMPROVING DIASTOLIC DYSFUNCTIONOctober 2010April 2021Allow6060YesYes
12889458LAPAROSCOPIC INSTRUMENT WITH ATTACHABLE END EFFECTORSeptember 2010June 2020Abandon6070NoNo
12884711EXPANDABLE MEDICAL DEVICESSeptember 2010May 2020Allow6090YesNo
12881245COMPRESSION SLEEVE WITH IMPROVED POSITION RETENTIONSeptember 2010May 2020Allow6070YesYes
12786743Catheter System and Method For Occluding A Body VesselMay 2010April 2020Allow6060YesYes
12787067VESSEL TREATMENT DEVICESMay 2010May 2023Allow60121YesYes
12771431EXTERNAL NASAL DILATORApril 2010November 2022Abandon6090NoYes
12540695APPARATUS AND METHODS FOR RETRIEVING AN OBJECT FROM A BODY PASSAGEAugust 2009June 2021Abandon6091NoNo
12515817Tunnel Tool for Soft TissueMay 2009August 2019Allow6060YesYes
12347442MODEL CATHETER INPUT DEVICEDecember 2008June 2020Abandon6080NoNo
12340816CannulaDecember 2008February 2020Allow6070YesNo
12287393Deployment handle for an implant deployment deviceOctober 2008October 2018Abandon6060YesNo
12172593EMBOLIC PROTECTION DEVICEJuly 2008August 2011Allow3720YesNo
11984668Endovascular devices and methods for exploiting intramural spaceNovember 2007September 2020Allow60101YesNo
10597901Stent for Use in Cardiac, Cranial, and Other ArteriesApril 2007November 2020Abandon60111NoNo
11368769BIFURCATED STENTMarch 2006July 2010Allow5260YesNo
11241027FILTER RETRIEVAL CATHETERSeptember 2005January 2011Allow6040NoYes
11226611Large diameter sheathSeptember 2005February 2020Abandon60110YesYes
11005934SHEATH FOR USE WITH AN EMBOLIC PROTECTION FILTERDecember 2004June 2011Allow6080YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner COLELLO, ERIN L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
6
Examiner Affirmed
4
(66.7%)
Examiner Reversed
2
(33.3%)
Reversal Percentile
55.3%
Higher than average

What This Means

With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
24
Allowed After Appeal Filing
5
(20.8%)
Not Allowed After Appeal Filing
19
(79.2%)
Filing Benefit Percentile
27.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner COLELLO, ERIN L - Prosecution Strategy Guide

Executive Summary

Examiner COLELLO, ERIN L works in Art Unit 3771 and has examined 85 patent applications in our dataset. With an allowance rate of 38.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.

Allowance Patterns

Examiner COLELLO, ERIN L's allowance rate of 38.8% places them in the 7% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by COLELLO, ERIN L receive 3.91 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by COLELLO, ERIN L is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +57.9% benefit to allowance rate for applications examined by COLELLO, ERIN L. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 9.0% of applications are subsequently allowed. This success rate is in the 4% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 14.7% of cases where such amendments are filed. This entry rate is in the 16% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 68.4% of appeals filed. This is in the 54% percentile among all examiners. Of these withdrawals, 46.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 31% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.4% of allowed cases (in the 76% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.